Search by Drug Name or NDC

    NDC 55292-0304-01 Tranxene 7.5 mg/1 Details

    Tranxene 7.5 mg/1

    Tranxene is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RECORDATI RARE DISEASES, INC.. The primary component is CLORAZEPATE DIPOTASSIUM.

    Product Information

    NDC 55292-0304
    Product ID 55292-304_894d45f5-ea77-47ba-be0b-8d46948ae800
    Associated GPIs 57100030100310
    GCN Sequence Number 003746
    GCN Sequence Number Description clorazepate dipotassium TABLET 7.5 MG ORAL
    HIC3 H20
    HIC3 Description ANTI-ANXIETY - BENZODIAZEPINES
    GCN 14093
    HICL Sequence Number 001612
    HICL Sequence Number Description CLORAZEPATE DIPOTASSIUM
    Brand/Generic Brand
    Proprietary Name Tranxene
    Proprietary Name Suffix T-Tab
    Non-Proprietary Name clorazepate dipotassium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 7.5
    Active Ingredient Units mg/1
    Substance Name CLORAZEPATE DIPOTASSIUM
    Labeler Name RECORDATI RARE DISEASES, INC.
    Pharmaceutical Class Benzodiazepine [EPC], Benzodiazepines [CS]
    DEA Schedule CIV
    Marketing Category NDA
    Application Number NDA017105
    Listing Certified Through 2022-12-31

    Package

    NDC 55292-0304-01 (55292030401)

    NDC Package Code 55292-304-01
    Billing NDC 55292030401
    Package 100 TABLET in 1 BOTTLE (55292-304-01)
    Marketing Start Date 1972-06-23
    NDC Exclude Flag N
    Pricing Information N/A